RecruitingNot ApplicableNCT06507332

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone

Combination Letrozole and Clomiphene Citrate Versus Letrozole Alone for Ovulation Induction in Women With Polycystic Ovary Syndrome: A Randomized Control Trial


Sponsor

Egymedicalpedia

Enrollment

64 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Clomiphene citrate is a non-steroidal triphenylethylene derivative distantly related to diethylstilbestrol. It acts as a selective estrogen receptor modulator (SERM), similar to tamoxifen and raloxifene. All three drugs are competitive inhibitors of estrogen binding to estrogen receptors (ERs) and have mixed agonist and antagonist activity, depending upon the target tissue. Letrozole is a potent, nonsteroidal, aromatase inhibitor, originally used for postmenopausal breast cancer therapy.


Eligibility

Sex: FEMALEMin Age: 20 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This study compares two treatments for inducing ovulation in women with polycystic ovary syndrome (PCOS) who are struggling to get pregnant: letrozole alone versus a combination of letrozole and clomiphene citrate (two different fertility medications). The goal is to find out if the combination leads to higher pregnancy rates. **You may be eligible if...** - You have been diagnosed with PCOS based on standard criteria (irregular periods, excess androgens, or polycystic ovaries on ultrasound) - You have been unable to get pregnant after 12 months of trying (or 6 months if over 35) - Your fallopian tubes are open and your partner has a normal semen analysis - You are capable of participating in the study **You may NOT be eligible if...** - You have unexplained infertility (another cause, not PCOS) - You have other causes of irregular ovulation (thyroid problems, high prolactin, Cushing's syndrome, adrenal problems) - You have endometrial hyperplasia or cancer - You are allergic to or cannot take letrozole or clomiphene - You have uncontrolled diabetes or high blood pressure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLetrozole 2.5mg

to assess and compare the efficacy of Combination of letrozole and clomiphene citrate versus letrozole alone for ovulation induction in women with polycystic ovary syndrome (PCOS)


Locations(1)

Ain Shams University Hospitals

Cairo, Abbasia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06507332


Related Trials